Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Androgens cause skin issues like acne and hair growth in women, often due to PCOS, and can be treated with medication and lifestyle changes.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

SHBG may be a useful early indicator and treatment target for PCOS.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Melatonin improved mental health and metabolism in women with PCOS.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.